| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.03 |